Regulatory impact statements

To help ensure the business compliance cost implications of regulatory proposals are explicit and comprehensively considered in developing policy, all policy proposals submitted to Cabinet require a regulatory impact statement (RIS). This section contains the Ministry's latest statements.

Where the policy proposal includes any compliance cost implications for business, these are set out in a business compliance cost statement (BCCS) within the regulatory impact statement.

Ministers and/or Cabinet may wish to review and amend the RIS/BCCS to ensure that they fully reflect the government's position and are of a high standard. Accordingly, some changes to the RIS/BCCS make take place after Cabinet consideration of the Cabinet submission.

Regulatory impact statements
Publication date Topic
16 December 2015 Substance Addiction (Compulsory Assessment and Treatment) Bill
30 November 2015 Reducing public harm from commercial sunbeds
30 September 2015 Home and Community Support (Payment for Travel Between Clients) Settlement Bill
26 May 2015 Medicines (Designated Prescriber: Dietitians) Regulations
09 December 2014 Changes to Radiation Safety Legislation
13 November 2014 Health Practitioners (Replacement of Statutory References to Medical Practitioners)
31 July 2014 Proposed Health (Protection) Amendment Bill
01 July 2014 Options to Reduce New Zealand’s Duty-free Tobacco Concessions
21 May 2014 Medicines (Designated Prescriber: Pharmacists) Regulations
06 May 2014 Amendment to the Psychoactive Substance Act 2013
02 December 2013 Problem Gambling Levy for 2010/11–2012/13
23 May 2013 Problem Gambling Levy for 2013/14 to 2015/16
17 May 2013 Government Response to the Family Carers Case
15 May 2013 Controlling the import sale and supply of high-power laser pointers
01 May 2013 Better retail controls on tobacco
20 July 2012 Plain packaging of tobacco products
11 July 2012 New regulatory regime for psychoactive substances
23 May 2012 Social Security (Long-term Residential Care: Budget Measures)
22 March 2012 Classification of Tapentadol under the Misuse of Drugs Act 1975
01 September 2011 Government Response to the Law Commission’s Report ‘Controlling and Regulating Drugs – a review of the Misuse of Drugs Act 1975’
Back to top